The 340B Drug Pricing Program remains one of the most important structural supports for health systems across the US, particularly those serving high-acuity and underserved populations. It allows covered entities to stretch limited resources and reinvest in patient care, especially in safety-net settings where reimbursement often does not fully reflect the cost of care.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
